iManage Cancer

• Research type

  Research Study

• Full title

  iManage Cancer - Empowering patients and strengthening self-management in cancer diseases

• IRAS ID

  213295

• Contact name

  Michael Douek

• Contact email

  michael.douek@kcl.ac.uk

• Sponsor organisation

  Director of Research Management and Innovation King’s College London

• Duration of Study in the UK

  1 years, 2 months, 22 days

• Research summary

  The study proposes to construct a risk model to predict neutropenic sepsis by analysing retrospectively collected patient data from Guy’s and St Thomas' NHS Foundation Trust. The data includes anonymised patient characteristics, chemotherapy treatment schedules, blood test results, complications and admissions to hospital.

• REC name

  East Midlands - Nottingham 1 Research Ethics Committee

• REC reference

  17/EM/0363

• Date of REC Opinion

  22 Sep 2017

• REC opinion

  Favourable Opinion